206 related articles for article (PubMed ID: 27174134)
1. Coumarins as cholinesterase inhibitors: A review.
de Souza LG; Rennã MN; Figueroa-Villar JD
Chem Biol Interact; 2016 Jul; 254():11-23. PubMed ID: 27174134
[TBL] [Abstract][Full Text] [Related]
2. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B; Singh N
Bioorg Med Chem; 2012 Feb; 20(3):1175-80. PubMed ID: 22257528
[TBL] [Abstract][Full Text] [Related]
3. A review on cholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B
Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Xie SS; Wang XB; Li JY; Yang L; Kong LY
Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
[TBL] [Abstract][Full Text] [Related]
6. Cholinesterases: new roles in brain function and in Alzheimer's disease.
Giacobini E
Neurochem Res; 2003 Apr; 28(3-4):515-22. PubMed ID: 12675140
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of Cholinesterases in Pharmacology: the Current Trends.
Pohanka M
Mini Rev Med Chem; 2020; 20(15):1532-1542. PubMed ID: 31656151
[TBL] [Abstract][Full Text] [Related]
8. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
[TBL] [Abstract][Full Text] [Related]
9. Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment.
Pinho BR; Ferreres F; Valentão P; Andrade PB
J Pharm Pharmacol; 2013 Dec; 65(12):1681-700. PubMed ID: 24236980
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors.
Nam SO; Park DH; Lee YH; Ryu JH; Lee YS
Bioorg Med Chem; 2014 Feb; 22(4):1262-7. PubMed ID: 24485122
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths].
Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN
Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726
[No Abstract] [Full Text] [Related]
12. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase.
Catto M; Pisani L; Leonetti F; Nicolotti O; Pesce P; Stefanachi A; Cellamare S; Carotti A
Bioorg Med Chem; 2013 Jan; 21(1):146-52. PubMed ID: 23199476
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids.
Huang L; Su T; Shan W; Luo Z; Sun Y; He F; Li X
Bioorg Med Chem; 2012 May; 20(9):3038-48. PubMed ID: 22472046
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1-42 Aggregation Inhibitors for Alzheimer's Disease Therapy.
Dgachi Y; Ismaili L; Knez D; Benchekroun M; Martin H; Szałaj N; Wehle S; Bautista-Aguilera OM; Luzet V; Bonnet A; Malawska B; Gobec S; Chioua M; Decker M; Chabchoub F; Marco-Contelles J
ChemMedChem; 2016 Jun; 11(12):1318-27. PubMed ID: 26804623
[TBL] [Abstract][Full Text] [Related]
15. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.
Piazzi L; Cavalli A; Colizzi F; Belluti F; Bartolini M; Mancini F; Recanatini M; Andrisano V; Rampa A
Bioorg Med Chem Lett; 2008 Jan; 18(1):423-6. PubMed ID: 17998161
[TBL] [Abstract][Full Text] [Related]
16. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
17. Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors.
Panek D; Wichur T; Godyń J; Pasieka A; Malawska B
Future Med Chem; 2017 Oct; 9(15):1835-1854. PubMed ID: 28925729
[TBL] [Abstract][Full Text] [Related]
18. Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases.
Farina R; Pisani L; Catto M; Nicolotti O; Gadaleta D; Denora N; Soto-Otero R; Mendez-Alvarez E; Passos CS; Muncipinto G; Altomare CD; Nurisso A; Carrupt PA; Carotti A
J Med Chem; 2015 Jul; 58(14):5561-78. PubMed ID: 26107513
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
Saeed A; Zaib S; Ashraf S; Iftikhar J; Muddassar M; Zhang KY; Iqbal J
Bioorg Chem; 2015 Dec; 63():58-63. PubMed ID: 26440714
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterases, a target of pharmacology and toxicology.
Pohanka M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):219-29. PubMed ID: 22286807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
